Spotlight on experiences of medicine unavailability: access to medicines challenges for NCDs and NTDs - the contrasting cases of insulin and praziquantel.

Expert Review of Clinical Pharmacology
Nadya WellsDavid Beran

Abstract

Effective medicines exist to address global health challenges including Neglected Tropical Diseases (NTD) and Noncommunicable Diseases (NCD) however these are often unavailable and unaffordable. To date, little literature exists comparing medicine unavailability across broad disease areas. Using insulin and praziquantel as tracer medicines this review aims to demonstrate that separating global health governance agendas for NCDs and NTDs ultimately impacts the effectiveness of coalitions for access for the poorest populations. Electronic literature searches were performed through Science Direct, PubMed, and Google Scholar (March-May2017 and updated in September-December2019) using keywords from Shiffman's framework; NCDs; NTDs; and for each medicine. Best practice from each area was analyzed. Many actors responded to the London Declaration which reinforced praziquantel's central role in control and elimination of schistosomiasis whereas access to affordable insulin emerged secondary to framing around prevention and management of diabetes. For insulin key stakeholders are not aligned around access. The position taken by pharmaceutical companies as donors versus commercial actors was critical to sustainable affordable access to th...Continue Reading

References

Nov 1, 2005·Lancet·Valentin Fuster, Janet Voûte
Feb 14, 2006·AIDS·Eyrun F KjetlandSvein Gunnar Gundersen
Nov 14, 2006·Lancet·Edwin A M Gale
Nov 14, 2006·Lancet·David Beran, John S Yudkin
Mar 7, 2008·Chronic Illness·Charles H King, Madeline Dangerfield-Cha
Sep 30, 2009·PLoS Neglected Tropical Diseases·Peter J Hotez, Alan Fenwick
Feb 23, 2010·Diabetes Research and Clinical Practice·Ping ZhangGregory Nichols
Aug 14, 2010·The Lancet Infectious Diseases·Darren J GrayAllen G Ross
Aug 17, 2010·Lancet·Peter J HotezLorenzo Savioli
Apr 9, 2011·Lancet·Robert BeagleholeUNKNOWN NCD Alliance
May 15, 2012·Acta Tropica·David RollinsonJürg Utzinger
Sep 15, 2012·BMJ : British Medical Journal·Peter J Hotez
Oct 12, 2012·Parasitology Research·Wei WangYou-Sheng Liang
Jun 24, 2014·Molecular and Biochemical Parasitology·Donato CioliAlessandra Guidi
Jul 25, 2014·PLoS Neglected Tropical Diseases·Peter J HotezMohsen Naghavi
Oct 12, 2014·The Lancet Global Health·David BeranJohn S Yudkin
Sep 1, 2013·Journal of Advanced Research·Rashida M R Barakat
Mar 19, 2015·The New England Journal of Medicine·Jeremy A Greene, Kevin R Riggs
May 23, 2015·Future Medicinal Chemistry·Alan Fenwick
Feb 10, 2016·The Lancet. Diabetes & Endocrinology·David BeranRichard Laing
Apr 5, 2016·Clinical Therapeutics·Joshua P CohenRobert Sturgeon
Apr 14, 2016·Health Policy and Planning·Jeremy ShiffmanDavid Pelletier
Jul 26, 2016·Journal of Pharmaceutical Policy and Practice·Warren A Kaplan, Reed F Beall
Jul 29, 2016·Nature·Christopher FitzpatrickDirk Engels
Oct 7, 2016·JAMA Oncology·Vinay PrasadSham Mailankody
Nov 12, 2016·Lancet·Veronika J WirtzMichael R Reich
Dec 17, 2016·Lancet·Artemis Koukounari, T Deirdre Hollingsworth
Dec 28, 2016·JAMA : the Journal of the American Medical Association·Joseph L DielemanChristopher J L Murray
Feb 13, 2017·The Lancet. Diabetes & Endocrinology·Jing LuoKasia J Lipska
Mar 24, 2017·Infectious Diseases of Poverty·Lorenzo SavioliXiao-Nong Zhou
Mar 30, 2017·Infectious Diseases of Poverty·Robert BergquistJennifer Keiser
Apr 21, 2017·PLoS Neglected Tropical Diseases·Dirk Engels

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.